ClinicalTrials.gg
Not yet recruitingNCT06983015Updated May 29, 2025

Sticky Bone vs Xenograft With Cross-linked Hyaluronic Acid in Socket Preservation

An interventional study of sticky bone and xenograft mixed with cross-linked hyaluronic acid in Socket Preservation, sponsored by Fayoum University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-29.

Sponsored by Fayoum University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The present study aimed to evaluate clinical and radiographic outcomes of sticky bone in comparison to crosslinked hyaluronic acid mixed with xenograft in alveolar ridge preservation.

Read the detailed description

After teeth extraction, the alveolar process goes through a remodeling process that leads to dimensional changes that end up with a decrease in the width and height of the alveolar bone; these changes happening after tooth loss proves that the alveolar process bone is tooth dependent.

Alveolar bone remodeling is a physiological process observed after tooth extraction that may compromise the subsequent dental implant rehabilitation. Most of the alveolar bone loss occurs during the first 3-6 months after tooth extraction, resulting in a bone width loss of 29-63%, which leads to difficulties restoring the teeth either with conventional prosthesis or with implant supported prosthesis and in many cases implant placement becomes a challenge.

To compensate for this alveolar remodeling and create an aesthetically implantsupported prosthesis, many bone grafting techniques were proposed, including guided bone regeneration, onlay bone block, and alveolar ridge preservation.

The latter is a prophylactic technique that involves inserting various biomaterials into the socket to reduce post-extraction changes. The two most commonly used bone grafting materials are allografts and xenografts. The Alveolar ridge preservation seeks to achieve successful ridge reconstruction, which involves the production of new bone within the volume of the old socket. Although xenografts provide steady and adequate bone volume maintenance, their healing time and the percentage of de novo bone production remain their main downside.

To improve alveolar ridge preservation outcomes, researchers are attempting to reduce the healing period so that implants can be placed shortly after tooth extraction. As a result, numerous growth factors were investigated as biological adjuvants to aid in the healing process and prevent physiological post-extractive bone loss. Recent researches studied the use of cross-linked hyaluronic acid (xHyA) gel as a biological adjuvant to xenograft in order to increase regeneration capacity and decrease post-extraction resorption Hyaluronic acid an extracellular polymer of disaccharides administration appears to have a beneficial impact on the healing process and bone cell response by stimulating mesenchymal cells proliferation, growth factors attraction and angiogenesis in situ. the cross-linked hyaluronic acid had been introduced with a slow degradation profile to maintain a longer presence. The combination of crosslinked hyaluronic acid mixed with xenograft was proved to be better than the xenograft only regarding post-extraction socket bone regeneration "Sticky bone" is a composite biomaterial designed for bone regeneration, combining particulate bone substitutes with autologous platelet aggregates, such as PRF and concentrated growth factors. This adaptable material conforms to various bony defects, preventing graft movement and preserving bone volume during healing, thus minimizing the need for block bone and titanium mesh.

The sticky bone had been used in socket preservation and provides good bone quality for further implant placement. The placement of sticky bone resulted in grafted material adherence to the recipient sites without micro and macro movements, and the PRF matrix prevented early epithelial ingross onto the defect site, resulting in significant new bone gain in both horizontal and vertical dimensions Sareen et al. reported in their systematic review that a major limitation was the lack of randomized controlled trials that provide evidence on alveolar ridge preservation with sticky bone. They recommend larger studies to evaluate the interest of sticky bone in various surgical procedures by comparing it with other existing materials and conventional techniques.

The present study aimed to evaluate clinical and radiographic outcomes of sticky bone in comparison to crosslinked hyaluronic acid mixed with xenograft in alveolar ridge preservation.

02

Conditions studied

  • Socket Preservation

Keywords

  • sticky bone
  • xenograft with cross-linked hyaluronic acid
03

In context

Lead sponsor

Fayoum University is the lead sponsor of 146 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age >18 years old.
  • Patient with hopeless maxillary anteriors and premolar with cl ii socket that needs extraction and delayed implant placement.

Exclusion criteria

Exclusion Criteria:

  • Acute abscesses or active infections localized in the proximity of the surgical field.
  • Presence of heavy metallic artefacts that can distort CBCT scans
  • Bad oral hygiene and non-compliance.
  • Systemic diseases interfering with bone healing.
  • Active and progressive periodontal disease
  • Smoking, alcoholism and drug abuse
  • Pregnant and lactating women
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    sticky bone

    patients in this group will undergo tooth extraction and immediate augmentation using sticky bone

    Procedure: sticky bone

  • Active comparator
    xenograft mixed with cross-linked hyaluronic acid

    patients in this group will undergo tooth extraction and immediate augmentation using xenograft mixed with cross-linked hyaluronic acid

    Procedure: xenograft mixed with cross-linked hyaluronic acid

Interventions

  • Proceduresticky bone

    extraction socket will be augmented using a sticky bone.

  • Procedurexenograft mixed with cross-linked hyaluronic acid

    Socket will be augmented with a mixture of xenograft and cross linked hyaluronic acid.

06

What researchers measure

Primary outcomes

  1. A standardized region of interest (ROI) will be calibrated for all sites, determined by following reference points

    A standardized region of interest (ROI) will be calibrated for all sites, determined by following reference points (8): * Apico-coronally: Coronally the most crestal bone peak will be detected mesially and distally; apically, an artificial line was drawn 1.5 mm below the most apical point of the root tip across the apical base of the socket. * Mesio-distally: limited by an artificial line at 1.5 mm distance of the most mesial and distal surface of adjacent tooth or implant. * Bucco-lingually: limited to the mostly detectable bone width extension.

    Time frame: This measurement will be obtained at immediate postoperative and 6-months postoperative.

Secondary outcomes

  1. Bone density

    Bone density: this will be measured immediately postoperative and at 6- monthpostoperative interval

    Time frame: This measurement will be obtained at immediate postoperative and 6-months postoperative.

  2. Postoperative Pain

    Postoperative Pain: will be assessed using pain score for assessment of quality of life measured on a 10-point visual analogue scale (VAS), the 0 indicating no pain and 10 indicating the worst pain ever at the following intervals: 1, 3, 7th day postoperative.

    Time frame: at the following intervals: 1, 3, 7th day postoperative.

  3. Bone volume

    Bone volume: alveolar ridge volumetric change, pre- and postoperative CBCT scans will be superimposed. In order to calculate the volumetric resorption rate (Percentage)

    Time frame: This measurement will be obtained at immediate postoperative and 6-months postoperative.

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2025; primary completion for Jun 2026, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 13, 2025
First posted
May 21, 2025
StartEst.
Jun 2025
Primary completionEst.
Jun 2026
CompletionEst.
Jul 2026
Last update
May 29, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06983015
Lead sponsor
Fayoum University
Responsible party
Ahmed Salah Ali Mohamed (oral and maxillofacial surgery master candidate, Fayoum University) — Principal investigator
First posted
May 21, 2025
Start date
Jun 2025 (estimated)
Primary completion
Jun 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
May 29, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion